Cytel operates a data-science-focused CRO built around SAS, R, and specialized clinical standards (CDISC SDTM/ADaM). The hiring mix is heavily skewed toward senior data and research roles (104 of 135 open roles), with minimal engineering or sales hires—reflecting a professional-services model where expertise and delivery quality drive revenue, not product velocity. Active workload spans the full drug-development cycle: trial design, statistical programming, regulatory submissions, and health-technology assessments.
Cytel is a clinical research organization (CRO) and data-science consultancy serving life-science companies across drug development and commercialization. Founded in 1987 and headquartered in Cambridge, Massachusetts, the company employs over 2,000 people across North America, Europe, and Asia. The service portfolio covers adaptive trial design, clinical data management, statistical analysis, regulatory submissions, and real-world evidence generation. Projects range from Phase I–IV studies to HTA dossier submissions and indirect treatment comparisons. Internal pain points center on budget/timeline forecasting accuracy, data-quality consistency across vendor networks, legacy-dataset migration, and compliance readiness—common pressures in scaling a consulting operation.
Cytel runs primarily on SAS, R, and Python for analytics; CDISC SDTM and ADaM for clinical data standards; React and Angular for front-end; PostgreSQL for data; and Medidata Rave for trial management. Jira, Confluence, and Git manage internal workflows.
Cytel has active hiring in 14 countries: United States, India, Ukraine, France, Canada, Sweden, Belgium, Colombia, Netherlands, Singapore, China, South Africa, Poland, and United Kingdom.
Other companies in the same industry, closest in size